Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Neurotrauma ; 41(5-6): 714-733, 2024 03.
Artigo em Inglês | MEDLINE | ID: mdl-37917117

RESUMO

Many military veterans who experienced blast-related traumatic brain injuries in the conflicts in Iraq and Afghanistan currently suffer from chronic cognitive and mental health problems that include depression and post-traumatic stress disorder (PTSD). Male rats exposed to repetitive low-level blast develop cognitive and PTSD-related behavioral traits that are present for more than 1 year after exposure. We previously reported that a group II metabotropic receptor (mGluR2/3) antagonist reversed blast-induced behavioral traits. In this report, we explored mGluR2/3 expression following blast exposure in male rats. Western blotting revealed that mGluR2 protein (but not mGluR3) was increased in all brain regions studied (anterior cortex, hippocampus, and amygdala) at 43 or 52 weeks after blast exposure but not at 2 weeks or 6 weeks. mGluR2 RNA was elevated at 52 weeks while mGluR3 was not. Immunohistochemical staining revealed no changes in the principally presynaptic localization of mGluR2 by blast exposure. Administering the mGluR2/3 antagonist LY341495 after behavioral traits had emerged rapidly reversed blast-induced effects on novel object recognition and cued fear responses 10 months following blast exposure. These studies support alterations in mGluR2 receptors as a key pathophysiological event following blast exposure and provide further support for group II metabotropic receptors as therapeutic targets in the neurobehavioral effects that follow blast injury.


Assuntos
Traumatismos por Explosões , Receptores de Glutamato Metabotrópico , Transtornos de Estresse Pós-Traumáticos , Masculino , Animais , Ratos , Ansiedade , Traumatismos por Explosões/complicações , Tonsila do Cerebelo
2.
PLoS One ; 7(6): e38475, 2012.
Artigo em Inglês | MEDLINE | ID: mdl-22685574

RESUMO

Spinal ligaments, such as the ligamentum flavum (LF), are prone to degeneration and iatrogenic injury that can lead to back pain and nerve dysfunction. Repair and regeneration strategies for these tissues are lacking, perhaps due to limited understanding of spinal ligament formation, the elaboration of its elastic fibers, maturation and homeostasis. Using immunohistochemistry and histology, we investigated murine LF elastogenesis and tissue formation from embryonic to mature postnatal stages. We characterized the spatiotemporal distribution of the key elastogenic proteins tropoelastin, fibrillin-1, fibulin-4 and lysyl oxidase. We found that elastogenesis begins in utero with the microfibril constituent fibrillin-1 staining intensely just before birth. Elastic fibers were first detected histologically at postnatal day (P) 7, the earliest stage at which tropoelastin and fibulin-4 stained intensely. From P7 to P28, elastic fibers grew in diameter and became straighter along the axis. The growth of elastic fibers coincided with intense staining of tropoelastin and fibulin-4 staining, possibly supporting a chaperone role for fibulin-4. These expression patterns correlated with reported skeletal and behavioral changes during murine development. This immunohistochemical characterization of elastogenesis of the LF will be useful for future studies investigating mechanisms for elastogenesis and developing new strategies for treatment or regeneration of spinal ligaments and other highly elastic tissues.


Assuntos
Proteínas da Matriz Extracelular/metabolismo , Ligamento Amarelo/metabolismo , Proteínas dos Microfilamentos/metabolismo , Proteína-Lisina 6-Oxidase/metabolismo , Tropoelastina/metabolismo , Animais , Tecido Elástico/embriologia , Tecido Elástico/crescimento & desenvolvimento , Tecido Elástico/metabolismo , Fibrilina-1 , Fibrilinas , Imuno-Histoquímica , Ligamento Amarelo/embriologia , Ligamento Amarelo/crescimento & desenvolvimento , Camundongos , Camundongos Endogâmicos C57BL , Camundongos Transgênicos , Fatores de Tempo
3.
Aust Fam Physician ; 39(6): 425-8, 2010 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-20628683

RESUMO

BACKGROUND: In order to understand more about pain presentations in primary care, the authors undertook a descriptive study on musculoskeletal pain presentations to a general practice with a special interest in musculoskeletal medicine. The aim was to describe and categorise musculoskeletal pain presentations into pain subtypes. METHODS: Over a 5 week period in 2009, 133 consecutive musculoskeletal pain patients consented to participate in a study on pain presentations. Patients were categorised into: somatic, somatic referred, neuropathic or a combination of these. Further information was collected on age, gender, length of attendance, mode of referral, and current pain history. RESULTS: Patients were predominantly female with chronic pain problems. Somatic low back pain was the commonest pain presentation. Neuropathic pain was a feature of 25% of cases, with pure somatic referred pain presenting in 1 in 7 cases. Nearly half of the patients were referred by their usual general practitioner. DISCUSSION Differentiating pain types is important in pain management. Neuropathic and somatic referred pain are common presentations to primary practice but may be difficult to detect. Data on pain presentation subtypes in primary practice is important to inform medical educators and research organisations and instruct future planning for primary care.


Assuntos
Medicina de Família e Comunidade , Doenças Musculoesqueléticas/fisiopatologia , Dor/fisiopatologia , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Criança , Pré-Escolar , Feminino , Humanos , Lactente , Recém-Nascido , Masculino , Pessoa de Meia-Idade , Doenças Musculoesqueléticas/epidemiologia , Dor/tratamento farmacológico , Dor/epidemiologia , Queensland/epidemiologia , Índice de Gravidade de Doença , Inquéritos e Questionários , Adulto Jovem
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...